Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | METAP2 | P50579 | 14/20 | 0.48 |
| ▸ | METAP1 | P53582 | 12/20 | 0.48 |
| ▸ | F2R | P25116 | 2/20 | 0.34 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.33 |
| ▸ | MAPT | P10636 | 1/20 | 0.32 |
| ▸ | RAB9A | P51151 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6487534 | 0.79 | METAP2 (0.64) | METAP2METAP1ALDH1A1 | |
| SCHEMBL6938548 | 0.74 | METAP2 (0.50) | METAP2METAP1 | |
| SCHEMBL6937947 | 0.72 | METAP2 (0.45) | METAP2METAP1 | |
| SCHEMBL21625558 | 0.70 | CA1 (0.49) | F2RALDH1A1MAPTRAB9A | |
| SCHEMBL30015441 | 0.70 | CA1 (0.49) | F2RALDH1A1MAPTRAB9A | |
| SCHEMBL6482866 | 0.68 | METAP2 (0.65) | METAP2METAP1ALDH1A1 | |
| SCHEMBL6489121 | 0.68 | METAP2 (0.77) | METAP2METAP1 | |
| SCHEMBL6477706 | 0.68 | METAP2 (0.61) | METAP2METAP1 | |
| SCHEMBL6477391 | 0.68 | METAP2 (0.67) | METAP2METAP1 | |
| SCHEMBL6489444 | 0.68 | METAP2 (0.67) | METAP2METAP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1272456-A1 | HYDRAZIDE AND ALKOXYAMIDE ANGIOGENESIS INHIBITORS | Abbott Laboratories (US) | 2003-01-08 | — | — | EP | claimed |
| WO-2001079157-A1 | HYDRAZIDE AND ALKOXYAMIDE ANGIOGENESIS INHIBITORS | ABBOTT LABORATORIES (US) | 2001-10-25 | — | — | WO | claimed |